News

Mindbloom and Happier Break New Ground with the Ultimate Fusion of Ketamine Therapy and Mindfulness

AUSTIN, Texas, Nov. 15, 2024 /PRNewswire/ -- Today, Mindbloom, the largest provider of psychedelic therapy, and Happier, the leading meditation and…

1 week ago

THIRA Health Welcomes Patricia Charles-Heathers, Ph.D., MPA, as New Executive Director

Seasoned Behavioral Health Leader Joins THIRA Health, Strengthening Commitment to Comprehensive Mental Health Care for Women and AdolescentsBELLEVUE, WA /…

1 week ago

DuneGlass Capital Announces the Launch of Aviva Aesthetics: The Industry’s Only Entrepreneur-Owned and Led Medical Aesthetics Platform

Aviva Aesthetics provides med spa owners with an alternative to private equity CHICAGO, IL and FULTON, MD / ACCESSWIRE /…

1 week ago

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders’ Equity Up 8.8% to $35M

Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands.Solid liquidity position, with cash…

1 week ago

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results

Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025Company…

1 week ago

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated…

1 week ago

Justera Health Announces Management Change

TORONTO, ON / ACCESSWIRE / November 15, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce…

1 week ago

Encision Reports Second Quarter Fiscal Year 2025 Results

BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active…

1 week ago

Theralase(R) Closes Non-Brokered Private Placement

TORONTO, ON / ACCESSWIRE / November 15, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 week ago